Joo Youn Kim

Joo Youn Kim

Auto-generated profile, based on publicly available information

Joo Youn Kim

Division of Healthcare Research & Research Planning, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SKSeung Hoon Kim
Seung Hoon Kim
HJHye Jin Joo
Hye Jin Joo
JKJoo Youn Kim
Joo Youn Kim
HKHyo Jeong Kim
Hyo Jeong Kim
Eun-Cheol ParkEun-Cheol Park
Eun-Cheol Park
Kim SH, et al. J Korean Med Sci. 2022 Sep;37(39):e284. https://doi.org/10.3346/jkms.2022.37.e284

15 September 2017 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
IHIn‐Chang Hwang
In‐Chang Hwang
SCSol Ji Choi
Sol Ji Choi
JCJi Eun Choi
Ji Eun Choi
EKEun‐Bi Ko
Eun‐Bi Ko
JSJae Kyung Suh
Jae Kyung Suh
JKJoo Youn Kim
Joo Youn Kim
Background: Controversies remain regarding clinical outcomes following initial strategies of coronary computed tomography angiography (CCTA) vs usual care with functional testing in patients with suspected coronary artery disease (CAD).Hypothesis: CCTA as initial diagnostic strategy results in better mid‐ to long‐term outcomes than usual care in patients with suspected CAD.Methods: We searched PubMed, Embase, and Cochrane Library for randomized controlled trials comparing clinical outcomes during ≥6 months' follow‐up between initial anatomical testing by CCTA vs usual care with functional testing in patients with suspected CAD. Occurrence of all‐cause mortality, nonfatal myocardial infarction (MI), and major adverse cardiovascular events (MACE), and use of invasive coronary angiography and coronary revascularization, were compared between the 2 diagnostic strategies.Results: Twelve trials were included (20 014 patients; mean follow‐up, 20.5 months). Patients undergoing CCTA as initial noninvasive testing had lower risk of nonfatal MI compared with those treated with usual care (risk ratio [RR]: 0.70, 95% confidence interval [CI]: 0.52‐0.94, P = 0.02). There was a tendency for reduced MACE following initial CCTA strategy, but not for risk of all‐cause mortality. Compared with functional testing, the CCTA strategy increased use of invasive coronary angiography (RR: 1.53, 95% CI: 1.12‐2.09, P = 0.007) and coronary revascularization (RR: 1.49, 95% CI: 1.11‐2.00, P = 0.007).Conclusions: Anatomical testing with CCTA as the initial noninvasive diagnostic modality in patients with suspected CAD resulted in lower risk of nonfatal MI than usual care with functional testing, at the expense of more frequent use of invasive procedures.

10 August 2020 in Journal of the Korean Medical Association
Verified
Journal Article
Open access
PDF file
MCMiyoung Choi
Miyoung Choi
HSHo Gyun Shin
Ho Gyun Shin
YJYan Jin
Yan Jin
JKJoo Youn Kim
Joo Youn Kim
KHKwang-Hyub Han
Kwang-Hyub Han
Since the confirmation of the first coronavirus disease 2019 (COVID-19) patient on January 20 2020, COVID-19 infection rate ramped up between February and March in South Korea. This study aimed to provide information on the characteristics of the first two months of COVID-19 prevalence in South Korea and attempted to comprehend preliminary evidence from various sources. We used public data available from the Korea Center for Disease Control and Prevention and situation reports from the World Health Organization from February to March 2020. For additional information, health utilization data from the Organization for Economic Co-operation and Development was used for subgroup analysis. A proportion of meta-analysis was performed. We searched literatures from PubMed, KoreaMed, and CNKI (China National Knowledge Infrastructure) for identifying epidemiological characteristics of COVID-19 and treatment strategies. We monitored domestic and global disease control institutions’ recommendations. The search results and reports were updated every two weeks. In South Korea, the ratio of confirmed cases is divided into two groups; before and after the occurrence of a large cluster infection explosion on February 17 2020 from a religious group called the Shincheonji Church. After the global pandemic announcement by World Health Organization on March 11 2020, the fatality rate of COVID-19 seems to be related to the number of beds and general hospitals. From the literature review, we identified a strong reproduction rate, asymptomatic period or infection, rate of exacerbation, and current treatments. The COVID-19 pandemic in South Korea was inevitable, but the early explosion of infection showed the decline curve afforded by the rigorous tracing, widespread testing, and well-organized health care system.